Corcept Therapeutics Shares Plunge 16.4% on Oil-Driven Market Pullback
Corcept Therapeutics shares plunged 16.44% Thursday, ranking among Russell 1000’s five biggest decliners. The drop coincided with a broad market pullback as WTI crude rose 2.5% to $66.65 a barrel on potential U.S.-Iran tensions, fueling sector rotations and weighing on small-cap biotechs.
1. Corcept Therapeutics' Stock Decline
Shares of Corcept Therapeutics fell 16.44% during Thursday’s session, making it one of the five largest decliners in the Russell 1000 index. The drop wiped out recent gains for the cortisol-inhibitor specialist and marked its steepest one-day loss in over a year.
2. Macro Market Influence
The broader market retreated as West Texas Intermediate crude futures jumped 2.5% to $66.65 a barrel on escalating U.S.-Iran tensions. Energy stocks led sector gains while small-cap biopharmaceuticals felt pressure from investor risk-off flows.